Best Tonsillectomy doctors: TOP 74 doctors

CURRICULUM VITAE

VOLKERT B. WREESMANN MD PhD

Consultant Otolaryngologist

Oncologic Head and Neck Surgeon

Thyroid and Parathyroid Surgeon

Facial Plastic Surgeon

Principal Positions

• Centro Medico Teknon, Barcelona, Spain

Chairman, Department of Otolaryngology-Head and Neck Surgery

July 1st 2024 – present

• Juaneda, Ciutadella Menorca, Spain

Consultant Otolaryngologist-Head and Neck Surgeon

January 2025 – present

• Avantmedic, Lleida, Spain

Consultant Otolaryngologist-Head and Neck Surgeon

July 1st 2024 – present

• Clinica Omega Zeta, Andorra

Consultant Otolaryngologist-Head and Neck Surgeon

March 1st 2022 – present

• University Hospitals Dorset NHS Foundation Trust

Consultant Otolaryngologist-Head and Neck Surgeon

August 1st 2021 – October 1st 2023

• Oxford University Hospitals NHS Foundation Trust

Honorary Consultant Otolaryngologist-Head and Neck Surgeon

May 1st 2021 – April 30th 2024

• Portsmouth Hospitals University NHS Trust, Portsmouth, UK

Consultant Otolaryngologist-Head and Neck Surgeon

July 18th 2016 – April 30th 2021

• Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK

Consultant Otolaryngologist-Head and Neck Surgeon

November 7th 2015 – May 31st 2016

• Heart of England NHS Trust, Birmingham, UK

Consultant Otolaryngologist-Head and Neck Surgeon

March 1st 2015 – October 31st 2015

• University Medical Center Utrecht, Netherlands

Consultant Otolaryngologist-Head and Neck Surgeon

November 1st 2013 – June 1st 2014

Memberships

• American Head and Neck Society – Member

Netherlands Academy of Otolaryngology - Member

Professional Licences

• United Kingdom

GMC Certification

Fully Registered Medical Practitioner with Specialist Registration with a License to Practice

Registered: 02/02/2015

GMC # 7499626

• United States of America

New York State Department of Health

New York State Education Department

Registered: July 2011

License# P80949

Physician

• Netherlands

Dutch Ministry of Health (BIG Registration)

BIG Registered: 22-06-2005

BIG #19063373601

Physician

Dutch Specialist Board (RGS)

RGS registered: 01-02-2011

RGS #1911979

Otolaryngology-Head and Neck Surgeon

• Spain

Collegi de Metges de Barcelona

COMB: 63638

• Andorra

Collegi de Metges d’Andorra

RPS: 03098

COMA: 876

Education

• Memorial Sloan-Kettering Cancer Center

Surgical Fellowship, Head and Neck Surgery

New York, New York, USA

August 1st 2011 - July 31st 2013

600 bed dedicated cancer center

Performed 1200 major oncologic head and neck resections in 2 years

• United States of America ECFMG Certification

United States Medical Licensing Examination (USMLE)

Certification: June 22nd, 2010

Scores: 

   Step I: 244/99 

   Step IIa-Clinical knowledge: 227/94

   Step IIb-Clinical Skills: PASSED

   Step III: 206/85

• Netherlands Cancer Institute

Surgical Fellowship, Head and Neck Surgery

Amsterdam, The Netherlands

February 1st 2011 - July 31st 2011

Specialized Head and Neck Cancer Surgery Department

200 bed hospital

• Amsterdam University Medical Center/Netherlands Cancer Institute

Residency Training, Otolaryngology-Head and Neck Surgery

Amsterdam, the Netherlands

February 1st 2006 – January 31st 2011

• University of Amsterdam School of Medicine

Medical Doctor (MD)

Amsterdam, the Netherlands

December 2002 - January 28th 2005

• University of Amsterdam

Doctor of Philosophy (PhD), Molecular Biology

Amsterdam, the Netherlands

Thesis title: Molecular-cytogenetic characterization of head and neck cancer

December 2nd, 2004

• Erasmus University School of Medicine

Doctoral Degree in Medicine

Rotterdam, the Netherlands

September 1994 - November 17th, 1998

Research Training

• Memorial Sloan-Kettering Cancer Center

Laboratory of Epithelial Cancer Biology, Head and Neck Service, Department of Surgery, New York, New York, USA

Research Fellowship in Molecular Oncology

Supervisors: Dr. Bhuvanesh Singh MD, PhD and Dr. Jatin P. Shah, MD, FACS

March 1st 1999 - September 30st 2002

• University of California San Francisco (UCSF)

Department of Otolaryngology-Head and Neck Surgery, San Francisco, California, USA

Post-doctoral Research Fellowship in Head and Neck Oncology

Supervisors: Dr. Steven Wang MD And Prof David Eisele MD

February 2005 - January 2006

Academic Activities

University of Amsterdam

Doctorate Examination Committee member

• September 17th, 2013 - PhD Candidate: Dr. I.J. Nixon (United Kingdom)
• October 17th 2014 - PhD Candidate: Dr. J. Pramana (Netherlands)
• November 17th 2015 - PhD candidate: Dr. H. van Monsjou (Netherlands)
• December 11th 2018 - PhD Candidate: Dr. Tihana Ibrahimpasic (United States)
• January 18th, 2021 - PhD Candidate: Dr. Laura Wang (Australia)
• June 2nd, 2021 - PhD Candidate: Dr. Caroline Verhagen (Netherlands)

Conference Faculty

• Advanced Laryngopharyngeal Cancer: Functional Preservation and Rehabilitation, Portsmouth, June 25th - 26th, 2020 (postponed due to COVID) - Chairman
• Functional Preservation and Rehabilitation after Treatment for Advanced Laryngeal Cancer, Portsmouth, March 14th - 15th, 2019 - Chairman
• Portsmouth Parathyroid Conference, Portsmouth, December 14th 2018 – Chairman

Editorial Roles

• European Journal of Surgical Oncology

Associate Editor

January 1st 2023 – present

• European Journal of Surgical Oncology

Guest Editor

March issue 2018, Volume 44, Issue 3, p275-378 - Special issue on thyroid cancer management

• Journal of Oral Pathology and Medicine

Guest Editor

November issue 2021, Volume 51, Issue 10 - Special issue on vascular malformations and tumors of the head and neck

• Scientific Journal Reviewer

Oral Oncology, European Journal of Surgical Oncology, Journal of Surgical Oncology, Head and Neck, International Journal of Cancer

• Scientific Project and Grant Reviewer

Netherlands: Dutch Cancer Society

France: Institute National du Cancer

Awards

• New York Head and Neck Society

Annual Meeting, New York, NY, March 2002

Title of study presented: “MUC1 is a target if 1q amplification and pertains a grave clinical prognosis in papillary thyroid cancer”

Invited Lectures

• European Society of Surgical Oncology meeting, Krakow, 2016
• Barcelona Society of Neurosurgery, Annual Meeting, Baqueira, Spain, February, 2017
• University of Edinburgh, Department of Otolaryngology Academic Conference, March 17th 2017
• Medilex: Performance of Medical Specialists, Zeist, Netherlands, November 9th 2017
• Medilex: Performance of Medical Specialists, Driebergen, Netherlands, October 11th 2017
• Wessex Head and Neck and Thyroid Network Education Day, May 3rd, 2017
• Portsmouth Parathyroid Conference, Portsmouth, UK, December 14th 2018
• Global Post-laryngectomy Rehabilitation Academy, Portsmouth, UK, March 14th 2019
• Health Care Quality Conference, Beverwijk, Netherlands, March 25th, 2019

Published Research Reports

• The growing precision of diagnostic pathways in thyroid nodule evaluation. 

Bekker J, Wreesmann VB. 

Eur J Surg Oncol. 2025 Jan;51(1):109374.

• Special issue: Management of vascular tumors and malformations of the head and neck. 

Oomen KPQ, Brennan PA, Wreesmann VB. 

J Oral Pathol Med. 2022 Nov;51(10):829.

• Angiosarcomas of the head and neck: Impact of large data analysis on clinical management.
•  
• Wreesmann VB, Oomen KP, Brennan PA.

J Oral Pathol Med. 2022 Nov;51(10):904-910.

• Current classification of vascular anomalies of the head and neck. 

Oomen KPQ, Wreesmann VB. 

J Oral Pathol Med. 2022 Nov;51(10):830-836.

• A novel classification of carotid body tumors.

Wreesmann VB, Nixon IJ. 

Eur. J. Surg. Oncol. May, 2021

• Management of the contralateral central neck in differentiated thyroid cancer: A contentious issue. 

Shaha AR, Tuttle RM, Wreesmann VB. 

Eur. J. Surg. Oncol. 2021 Apr;47(4):717-719.

• Improvement of oral cancer screening quality and reach: The promise of artificial intelligence.
•  
• Kar A, Wreesmann VB, Shwetha V, Thakur S, Rao VUS, Arakeri G, Brennan PA.

J Oral Pathol Med. 2020 Mar 11

• The risk-benefit ratio of chemoradiation treatment in head and neck squamous cell carcinoma: value of extranodal spread and margin status. 

Ammar M, Wreesmann VB. 

Journal of ENT Masterclass, Yearbook 2018, Volume 11, Nr. 1, December 1st, 2018

• Nasal obstruction secondary to an inverted midline supernumerary tooth. 

Jones L, Hilton JM, Heyman J, Viswanathan H, Wreesmann VB, Hayes SM. 

Ann R Coll Surg Engl. 2019 Jan;101(1)

• Fanconi anemia and homologous recombination gene variants are associated with functional DNA repair defects in vitro and poor outcome in patients with advanced head and neck squamous cell carcinoma. 

Verhagen CVM, Vossen DM, Borgmann K, Hageman F, Grénman R, Verwijs-Janssen M, Mout L, Kluin RJC, Nieuwland M, Severson TM, Velds A, Kerkhoven R, O'Connor MJ, van der Heijden M, van Velthuysen ML, Verheij M, Wreesmann VB, Wessels LFA, van den Brekel MWM, Vens C. 

Oncotarget. 2018 Apr 6;9(26):18198-18213.

• Complete nasal obstruction secondary to pacemaker insertion. 

Jones TL, Wreesmann VB, Nilssen E, Hilton J, Hayes SM. 

Ann R Coll Surg Engl. 2018 May;100(5)

• Optimization of the risk-benefit ratio of differentiated thyroid cancer treatment. 

Nasef HO, Nixon IJ, Wreesmann VB. Eur J Surg Oncol. 

2018 Mar;44(3):276-285. Review.

• The risk/benefit ratio of differentiated thyroid cancer treatment: Exploring treatment de-escalation. 

Wreesmann VB; on behalf of EJSO. 

Eur J Surg Oncol. 2018 Mar;44(3):275.

• Aggressive differentiated thyroid cancer. 

Janjua N, Wreesmann VB. 

Eur J Surg Oncol. 2018 Mar;44(3):367-377. Review.

• Role of extracapsular nodal spread and surgical margin status in defining high-risk head and neck squamous cell carcinoma and its treatment intensity. 

Wreesmann VB. 

International Journal of Head and Neck Surgery, April-June 2017; 8(2): 76-83.

• An International Multi-Institutional Validation of Age 55 Years as a Cutoff for Risk Stratification in the AJCC/UICC Staging System for Well-Differentiated Thyroid Cancer.              

Nixon IJ, Wang LY, Migliacci JC, Eskander A, Campbell MJ, Aniss A, Morris L, Vaisman F, Corbo R, Momesso D, Vaisman M, Carvalho A, Learoyd D, Leslie WD, Nason RW, Kuk D, Wreesmann V, Morris L, Palmer FL, Ganly I, Patel SG, Singh B, Tuttle RM, Shaha AR, Gönen M, Pathak KA, Shen WT, Sywak M, Kowalski L, Freeman J, Perrier N, Shah JP. 

Thyroid. 2016 Mar;26(3):373-80.

• Influence of extracapsular nodal spread extent on prognosis of oral squamous cell carcinoma. 
•  
• Wreesmann VB, Katabi N, Palmer FL, Montero PH, Migliacci JC, Gönen M, Carlson D, Ganly I, Shah JP, Ghossein R, Patel SG.

Head Neck. 2016 Apr;38 Suppl 1:E1192-9.

• Defining a Valid Age Cutoff in Staging of Well-Differentiated Thyroid Cancer. 

Nixon IJ, Kuk D, Wreesmann V, Morris L, Palmer FL, Ganly I, Patel SG, Singh B, Tuttle RM, Shaha AR, Gönen M, Shah JP. 

Ann Surg Oncol. 2015 Jul 28.

• Prognostic value of vascular invasion in well-differentiated papillary thyroid carcinoma.
•  
• Wreesmann VB, Nixon IJ, Rivera M, Katabi N, Palmer F, Ganly I, Shaha AR, Tuttle RM, Shah JP, Patel SG, Ghossein RA.

Thyroid. 2015 May;25(5):503-8.

• Head and neck squamous cell carcinoma in young patients.

van Monsjou HS, Wreesmann VB, van den Brekel MW, Balm AJ. 

Oral Oncol. 2013 Dec;49(12):1097-102.

• Oral and oropharyngeal squamous cell carcinomas in young patients: The Netherlands Cancer Institute experience. 

van Monsjou HS, M Lopez-Yurda, M. Hauptmann, Balm AJ, van den Brekel MM, Wreesmann VB. 

Head Neck. 2013 Jan;35(1):94-102.

• Oropharyngeal squamous cell carcinoma: a unique disease on the rise?

van Monsjou HS, Balm AJ, van den Brekel MM, Wreesmann VB. 

Oral Oncol. 2010 Nov;46(11):780-5.

• Closure of tracheoesophageal fistula with prefabricated revascularized bilaminar radial forearm free flap.

Wreesmann VB, Smeele LE, Hilgers FJ, Lohuis PJ. 

Head Neck. 2009 Jun;31(6):838-42.

• Clinical impact of molecular analysis on thyroid cancer management.

Wreesmann VB, Singh B. 

Surg Oncol Clin N Am. 2008 Jan;17(1):1-35.

Genetic abnormalities associated with chemoradiation resistance of head and neck squamous cell carcinoma. 

van den Broek GB, Wreesmann VB, van den Brekel MW, Rasch CR, Balm AJ, Rao PH. 

Clin Cancer Res. 2007 Aug 1;13(15 Pt 1):4386-91.

• Association of CD44 V3-containing isoforms with tumor cell growth, migration, matrix metalloproteinase expression, and lymph node metastasis in head and neck cancer.

Wang SJ, Wreesmann VB, Bourguignon LY. 

Head Neck. 2007 Jun;29(6):550-8.

• Downregulation of Fanconi anemia genes in sporadic head and neck squamous cell carcinoma.
•  
• Wreesmann VB, Estilo C, Eisele DW, Singh B, Wang SJ.

ORL J Otorhinolaryngol Relat Spec. 2007;69(4):218-25. Epub 2007 Apr 4.

• Patterns of expression of cell cycle/apoptosis genes along the spectrum of thyroid carcinoma progression.
•  
• Saltman B, Singh B, Hedvat CV, Wreesmann VB, Ghossein R.
•  
• Surgery. 2006 Dec;140(6):899-905; discussion 905-6.

• Repetitive endoscopic sinus surgery failure: a role for radical surgery?

Videler WJ, Wreesmann VB, van der Meulen FW, Knegt PP, Fokkens WJ. 

Otolaryngol Head Neck Surg. 2006 Apr;134(4):586-91.

• MUC1 plays a role in tumor maintenance in aggressive thyroid carcinomas.
•  
• Patel KN, Maghami E, Wreesmann VB, Shaha AR, Shah JP, Ghossein R, Singh B.
•  
• Surgery. 2005 Dec;138(6):994-1001; discussion 1001-2.

• Chromosomal aberrations in squamous cell carcinomas of the upper aerodigestive tract: biologic insights and clinical opportunities.

Wreesmann VB, Singh B. 

J Oral Pathol Med. 2005 Sep;34(8):449-59. Review.

• Molecular profiling of tumor progression in head and neck cancer.
•  
• Belbin TJ, Singh B, Smith RV, Socci ND, Wreesmann VB, Sanchez-Carbayo M, Masterson J, Patel S, Cordon-Cardo C, Prystowsky MB, Childs G.
•  
• Arch Otolaryngol Head Neck Surg. 2005 Jan;131(1):10-8.

• Identification of novel prognosticators of outcome in squamous cell carcinoma of the head and neck.

Wreesmann VB, Shi W, Thaler HT, Poluri A, Kraus DH, Pfister D, Shaha AR, Shah JP, Rao PH, Singh B. 

J Clin Oncol. 2004 Oct 1;22(19):3965-72.

• Follicular variant of papillary thyroid carcinoma: genome-wide appraisal of a controversial entity.

Wreesmann VB, Ghossein RA, Hezel M, Banerjee D, Shaha AR, Tuttle RM, Shah JP, Rao PH, Singh B. 

Genes Chromosomes Cancer. 2004 Aug;40(4):355-64.

• Genome-wide profiling of papillary thyroid cancer identifies MUC1 as an independent prognostic marker.

Wreesmann VB, Sieczka EM, Socci ND, Hezel M, Belbin TJ, Childs G, Patel SG, Patel KN, Tallini G, Prystowsky M, Shaha AR, Kraus D, Shah JP, Rao PH, Ghossein R, Singh B. 

Cancer Res. 2004 Jun 1;64(11):3780-9.

• Genetic abnormalities associated with nodal metastasis in head and neck cancer.

Wreesmann VB, Wang D, Goberdhan A, Prasad M, Ngai I, Schnaser EA, Sacks PG, Singh B. 

Head Neck. 2004 Jan;26(1):10-5.

• Human papillomavirus DNA and p53 polymorphisms in squamous cell carcinomas from Fanconi anemia patients.
•  
• Kutler DI, Wreesmann VB, Goberdhan A, Ben-Porat L, Satagopan J, Ngai I, Huvos AG, Giampietro P, Levran O, Pujara K, Diotti R, Carlson D, Huryn LA, Auerbach AD, Singh B.
•  
• J Natl Cancer Inst. 2003 Nov 19;95(22):1718-21.

• Chromosomal aberrations in patients with head and neck squamous cell carcinoma do not vary based on severity of tobacco/alcohol exposure.

Singh B, Wreesmann VB, Pfister D, Poluri A, Shaha AR, Kraus D, Shah JP, Rao PH. 

BMC Genet. 2002 Nov 14;3:22. Epub 2002 Nov 14.

• Genome-wide appraisal of thyroid cancer progression.
•  
• Wreesmann VB, Ghossein RA, Patel SG, Harris CP, Schnaser EA, Shaha AR, Tuttle RM, Shah JP, Rao PH, Singh B.
•  
• Am J Pathol. 2002 Nov;161(5):1549-56.

• Refractory chronic sinusitis: evaluation of symptom improvement after Denker’s procedure.
•  
• Wreesmann VB, Fokkens WJ, Knegt PP.
•  
• Otolaryngol Head Neck Surg. 2001 Nov;125(5):495-500.

• Inflammatory pseudotumour (inflammatory myofibroblastic tumour) of the pancreas: a report of six cases associated with obliterative phlebitis.
•  
• Wreesmann V, van Eijck CH, Naus DC, van Velthuysen ML, Jeekel J, Mooi WJ.
•  
• Histopathology. 2001 Feb;38(2):105-10.

• Screening for genetic aberrations in papillary thyroid cancer by using comparative genomic hybridization.
•  
• Singh B, Lim D, Cigudosa JC, Ghossein R, Shaha AR, Poluri A, Wreesmann VB, Tuttle M, Shah JP, Rao PH.
•  
• Surgery. 2000 Dec;128(6):888-93;discussion 893-4.

Abstracts (Presentations at scientific meetings):

• Genome-wide screening for genetic prognostic factors in papillary thyroid carcinoma.
•  
• Wreesmann VB, Ghossein RA, Poluri A, Shaha AR, Tuttle RM, Shah JP Rao PH, Singh B.

Fifth International Conference on Head and Neck Cancer San Francisco, CA, July 2000.

• Hierarchical Clustering (HC): a Novel Approach to Evaluating the Prognostic Value of Laboratory Parameters in Patients (Pts) Undergoing Chemoradiation Treatment (CRT) for Advanced Laryngopharyngeal Carcinoma (LPC). 

Singh B, Pfister D, Wreesmann VB, Li R, Gogineni S, Bosl G, Hoffman RH, Shah JP, Rao PH. 

37th Annual Meeting of the American Society of Clinical Oncology; New Orleans LA, May 2001.

• Gain of 1q is unique to the tall cell variant of papillary thyroid cancer.

Wreesmann VB, Ghossein RA, Tuttle RM, Shaha AR, Robbins R, Shah JP, Rao PH, Singh B. 

73rd annual meeting of the American Thyroid Association, Washington D.C. November 2001.

• MUC1 is a target of 1q amplification and pertains a grave clinical prognosis in papillary thyroid cancer. 

Wreesmann VB, Sieczka E, Socci ND, Hezel M, Belbin TJ, Childs G, Patel SG, Shah JP, Rao PH, Ghossein RG, Singh B. 

Annual Meeting of the New York Head and Neck Society, New York, NY, March 2002.

• Genome wide screening identified gains and losses as independent prognostic variables in patients with head and neck squamous cell carcinoma (HNSCC). 

Singh B, Wreesmann VB, Thaler HT, Shi W, Shah JP, Shaha AR, Kraus DH, Boyle JO, Pfister D, Rao PH. 

38th Annual Meeting of the American Society of Clinical Oncology; Orlando, Fl May 2002.

• p53 inactivation by human papillomavirus (HPV) in Fanconi anemia associated squamous cell carcinoma. 

Kutler DI, Goberdhan A, Wreesmann VB, Giampietro PF, Auerbach AD, Singh B. 

The Sixth Research Workshop on the Biology, Prevention, and Treatment of Head and Neck Cancer; Washington D.C.; October 2002.

• Identification of novel prognostic factors in head and neck squamous cell carcinoma. 
•  
• Wreesmann VB, Shi W, Thaler HT, Shah JP, Shaha AR, Kraus DH, Boyle JO, Pfister D, Rao PH, Singh B. 

7th symposion on Research in Head and Neck Cancer; Dusseldorf, Germany, September 4-6 2003.

• Molecular profiling of aggressive papillary thyroid cancer: prognostic significance of MUC1 alterations. 

Wreesmann VB, Sieczka E, Socci ND, Hezel M, Belbin TJ, Childs G, Patel SG, Patel KN, Tallini G, Prystowsky M, Shaha AR, Kraus D, Shah JP, Rao PH, Ghossein RA, Singh B. 

7th symposion on Research in Head and Neck Cancer; Dusseldorf, Germany, September 4-6 2003.

• Chromosomal aberrations in Fanconi anemia-associated squamous cell carcinomas differ from sporadic squamous cell carcinomas from the general population. 

Kutler DI, Rao PH, Wreesmann VB, Goberdhan A, Ngai I, Huvos AG, Giampietro PF, Levran O, Pujara K, Diotti R, Auerbach AD, Singh B. 

15th annual Fanconi Anemia Research Fund scientific symposium, Houston TX, Oct 2003.

• Molecular classification of Fanconi anemia(FA)-associated head and neck squamous cell carcinoma (HNSCC) using oligonucleotide microarrays. 

Kutler DI, Ganly I, Wreesmann VB, Goberdhan A, Ngai I, Huvos AG, Giampietro PF, Levran O, Pujara K, Diotti R, Auerbach AD, Singh B. 

15th annual Fanconi Anemia Research Fund scientific symposium, Houston TX, Oct 2003.

•  
• Genotyping follicular cell-derived thyroid neoplasia: a CGH study of 150 cases.

Wreesmann VB, Ghossein RA, Socci N, Shaha AR, Tuttle RM, Shah JP, Rao PH, Singh B. 

Sixth International Conference on Head and Neck Cancer, Washington DC, August 2004.

• Downregulation of Fanconi anemia genes in sporadic squamous cell carcinomas of the head and neck. 

Wreesmann VB, Estilo C, Eisele DW, Singh B, Wang SJ. 

208th meeting of the Netherlands Society of Otolaryngology-Head and Neck Surgery, Utrecht, April 7th 2006.

• Extracapsular nodal spread does not predict outcome in clinically node negative oral cavity squamous cell carcinoma. 

Wreesmann VB, Ghossein RA, Carlson D, Ganly I, Palmer F, Montero P, Shah JP, Patel SG. 

AHNS 2013 Annual Meeting, April 10 & 11, 2013, Orlando Florida.

• Minor (<2mm) extracapsular spread is not an adverse predictor of outcome in metastatic squamous cell carcinoma of the oral cavity. 

Wreesmann VB, Ghossein RA, Carlson D, Ganly I, Palmer F, Montero P, Shah JP, Patel SG. Presented at the AHNS 2014 Annual Meeting, July 2014, New York, New York.

Books, Chapters:

• Molecular Biology as applied to Head and Neck Oncology

Wreesmann VB, Singh B.

Stell and Maran's Textbook of Head and Neck Surgery and Oncology

Fifth Edition

Chapter, edited by John Watkinson and Ralph Gilbert

• Molecular-Cytogenetic Characterization of Head and Neck Cancer: Identification of molecular prognostic factors and targets of therapy

Wreesmann VB, Singh B.

Book, Amsterdam 2004

Reviewed in: Head and Neck: Volume 29, Issue 1, pages 82–83, January 2007

• Open Conservation Surgery for Laryngeal Cancer

Wreesmann VB, Ganly I

Scott-Brown's Otorhinolaryngology and Head and Neck Surgery, Eighth Edition

Chapter 27

CRC Press, Taylor-Francis Group, June 12th, 2018

• Molecular Oncology

Wreesmann V.B.

Self-Assessment in Head and Neck Surgery and Oncology, First Edition

Chapter 21

Elsevier 2014

Research grants:

Netherlands Cancer Institute “Startgeld” Grant 2008

Project: Fanconi anemia in head and neck cancer

Principal investigators: Wreesmann VB, van den Brekel MW, Balm AJM, Vens C.

Amount granted: 300.000 euro

Eğitim ve Uzmanlık
2010/2016 Afyon Kocatepe Üniversitesi Tıp Fakültesi
2017/2022 SBÜ Antalya Eğitim ve Araştırma Hastanesi KBB Kliniği Tıpta Uzmanlık Eğitimi

Deneyim
2016/2017 Afyonkarahisar Sinanpaşa Toplum Sağlığı Merkezi
2017/2023 Antalya Eğitim ve Araştırma Hastanesi
2023/2024 Afyonkarahisar Dinar Devlet Hastanesi
 

Prof. Dr. Celil Göçer is a respected ENT specialist known for his work in otolaryngology. He has published over 30 scientific articles in international journals. His research covers hearing loss, laryngeal cancer, sinus diseases, rare conditions, and new surgical techniques. He has also co-authored ENT books and written chapters for major surgical references.

Dr. Göçer often presents at national and international conferences. He shares research on cochlear implants, paranasal tumors, and how hearing aids affect tinnitus in older adults. He is recognized for his skill in clinical care and surgical training, especially in stapedectomy procedures.

He received advanced training at the House Ear Institute in the USA. Since 2011, he has been a professor at Lokman Hekim Health Group, where he helps shape ENT practice and research in Turkey.

Dr. Sezgin Bekdemir is a distinguished Ear, Nose, and Throat (ENT) specialist based in İzmir, Turkey. Born in 1974 in Bulancak, Giresun, he completed his secondary education in Giresun before enrolling at the 19 May University Medical Faculty in Samsun in 1992. In 2000, he pursued specialization in ENT at Erzurum Atatürk University Medical Faculty, completing his residency in 2004.

Following his specialization, Dr. Bekdemir served at Otlu Government Hospital and Erzurum Numune Hospital. In 2005, he began working at Erzurum Private Recovery Hospital.

Currently, Dr. Bekdemir practices at the ENTO ENT Surgical Medical Center in Bornova, İzmir. The center, established in 2001, is renowned for its advanced technologies and specialized services in otorhinolaryngology, nasal aesthetics (rhinoplasty), dermatology, hair transplantation, sleep disorders (including sleep apnea and snoring), and hearing assessments.

Prapas Teerakul , M.D.

Otolaryngology specialist

Graduated (M.D. From)

Doctor of Medicine, Faculty of Medicine, Ramathibodi Hospital, Mahidol University

Specialize in this area are called otorhinolaryngologists, otolaryngologists, head and neck surgeons, or ENT surgeons or physicians

Certificates

Certificate of Otolaryngology, Ramathibodi Hospital

Work experience

Assistant Professor, Department of Otolaryngology, Faculty of Medicine, Ramathibodi Hospital, Mahidol University

Current Positions

Otolaryngologist at Intrarat Hospital

Op. Dr. Yasemin Ongun is a specialist in Ear, Nose, and Throat (ENT) and Head & Neck Surgery. She graduated from Kocaeli University Faculty of Medicine in 2005. In 2008, she completed advanced training in Otology-Neurotology, Audiology, and Head and Neck Surgery at Hacettepe University.

Dr. Ongun has worked in both public and private healthcare settings. She served at Şanlıurfa Mehmet Akif İnan Training and Research Hospital and held the position of deputy chief physician in private hospitals. She has performed many surgeries, with a focus on rhinoplasty, endoscopic sinus surgery, pediatric ENT procedures, otoplasty, and hearing-related operations.

Academic and Professional Background

• Education:
  • 1990–1996: Hacettepe University Faculty of Medicine (MD).
  • 1996–2000: Residency in ENT at Ankara Training and Research Hospital.
  • 2002: Advanced training at the House Ear Institute, Los Angeles, USA.
• Professional Experience:
  • Various roles including researcher, specialist, and chief at prominent hospitals in Turkey.
  • Since 2011: Professor at Lokman Hekim Health Group, focusing on ENT diseases.

Key Achievements and Research Contributions

• Published Work:
  • Over 30 scientific articles in international journals on ENT topics such as hearing loss, laryngeal cancer, and sinus conditions.
  • Topics include rare diseases, surgical innovations, and radiological evaluations.
  • Co-author of ENT-related books and translated chapters in notable surgical references.
• Conference Presentations:
  • Frequent presenter at national and international scientific meetings.
  • Delivered groundbreaking studies on cochlear implants, paranasal tumors, and hearing aid effects on geriatric tinnitus.
• Awards & Recognition:
  • Recognized for excellence in clinical practice and surgical training models, particularly in stapedectomy.

Clinical and Research Interests

• Diseases of the ear, nose, and throat, with a focus on: 
  • Hearing disorders (sensorineural, conductive, age-related).
  • Rhinological conditions, including sinusitis and mucosal pathologies.
  • Oncological ENT cases, specifically rare cancers of the larynx and paranasal sinuses.

International Training and Professional Development

• Attended multiple specialized courses at the House Ear Institute (USA) focusing on temporal bone surgery and pathology.
• Participation in advanced workshops and conferences such as the American Academy of Otolaryngology–Head and Neck Surgery Foundation (AAO-HNSF).

Publications and Citations

• Authored high-impact studies cited in prominent journals.
• Contributions to understanding ENT disorders through innovative research methods, such as temporal bone dissection and immunohistochemistry.

Prof. Dr. Celil Göçer is a distinguished ENT specialist whose extensive clinical expertise and academic contributions have greatly influenced the field. He is highly regarded for his innovative surgical approaches and dedication to advancing medical knowledge.

Medical Doctor Medical Faculty

Ankara University

1996-2002

Otorhinolaryngology

Department of ENT

Yıldırım Beyazıt Education and Research Hospital

2002-2008

Assoc.Prof.

Department of ENT

Kanuni Education and Research Hospital

2014

Prof.

Department of ENT

University of Avrasya

2021

Thesis:

Comparison of montelukast and mometasone furoate in the prevention of recurrent nasal polyps

Thesis adviser: İstemihan Akın, Assoc. Prof.

Employment history

Official Title

Years

Otorhinolaryngology, Researcher

Dışkapı Yıldırım Beyazıt Education and Research Hospital, ENT Clinic

2002-2008

Specialist

Dışkapı Yıldırım Beyazıt Education and Research Hospital

2008-2011

Specialist

Trabzon Kanuni Education and Research Hospital

2011-2018

Asoc.Prof.

Trabzon Kanuni Education and Research Hospital

2014-2021

Prof.

University of Avrasya

2021

Foreign language knowledge

English, Advanced level

Research interests

My principal research interests lie in the fields of head, neck, tyroid, endoscopic sinus surgery, cochlear implantation and otologic surgery.

Professional memberships

Turkish Association of Otorhinolaryngology

Turkish Association of Rhinology

Membership of editorial board

Journal of Clinical and Analytical Medicine

Indian Journal of Otolaryngology and Head & Neck Surgery

Turkish Board Certificate:

1.Turkish ORL-HNS Board Certificate, December 2010, İzmir

2.Turkish ORL-HNS, Head Neck and Tyroid Surgery School, 2014

Awards:

2010- The protective effects of E, B, C vitamins and L-carnitine in the prevention of the cisplatin-induced ototoxicity in rats. 1st National Otology-Neurootology Congress, Gazimagosa, KKTC, 12-16. May. 2010

2010- Sinonasal disease association of paranasal sinus anatomic variations, 6. National Rinology Congress, Antalya, 19-23. May. 2010.

2010- The effects of L-carnitine local use after myringotomy on myringosclerosis development in rats. 32nd Turkish National ORL-HNS Congress, Antalya, 27-31. October. 2010.

A.Articles published in international refereed journals:

A1. Vuralkan E, Saka C, Akın İ, Hücümenoğlu S, Uzmez Unal B, Kuran G, Öcal B. Comparison of montelukast and mometasone furoate in the prevention of recurrent nasal polyps. Ther Adv Respir Dis 2012; 6(1) 5–10 DOI: 10.1177/ 1753465811427577

A2. Saka C, Vuralkan E, Fırat IH, Alicura S, Hücümenoğlu S, Akın I, Ardıç S, Gökler A. The effects of CPAP treatment on nasal mucosa in patients with obstructive sleep apnea. Eur Arch Otorhinolaryngol 2012 Sep;269(9):2065-7. Doi: 10.1007/s00405-011-1906-2. Epub 2012 Jan 3

A3. Tokgöz Alicura S, Vuralkan E, Sonbay ND, Çalışkan M, Saka C, Beşaltı Ö, Akın İ. The protective effects of E, B, C vitamins and L-carnitine in the prevention of the cisplatin-induced ototoxicity in rats. J Laryngol Otol 2012 May;126(5):464-9. Epub 2012 Apr 11

A4. Simşek G, Tokgoz SA, Vuralkan E, Caliskan M, Besalti O, Akin I. Protective effects of resveratrol on cisplatin-dependent inner-ear damage in rats. Eur Arch Otorhinolaryngol 2012 Sep 22. [Epub ahead of print]

A5. Vuralkan E, Alicura Tokgoz S, Simsek G, Koybasioglu F, Han Ü, Caliskan M, Besalti Ö, Akin İ. The effects of L-carnitine local use after myringotomy on myringosclerosis development in rats. J Laryngol Otol 2012

A6. Sonbay ND, Saka C, Tatlican S, Vuralkan E, Aygener N, Eren C. Audiologic evaluation in patients with Behcet`s Disease. J Laryngol Otol 2012

A7. Gunsoy B, Vuralkan E, Sonbay ND, Simsek G, Alicura Tokgoz S, Akin İ. Quality of Life Following Surgical Treatment of Benign Parotid Disease. Indian J Otolaryngol Head Neck Surg DOI 10.1007/s12070-012-0585-7

A8. Kuran G, Vuralkan E, Saka C, Akın İ. Endoscopic sinus surgery of frontal mucocele. J Pak Med Assoc 2007;57(11):570-1

A9. Şimşek G, Vuralkan E, Ceylan BT, Akın İ, Han Ü. Mucoepidermoid carcinoma in the larynx successfully treated by radiotherapy: a case report” Capsula Eburnea 2009; 4(30): 123-128

A10. Kuran G, Ide T, Ceylan T, Sirin Y, Yılmazer D, Vuralkan E. The effect of topical phenytoin application on traumatic tympanic membrane perforation. The Journal of International Advanced Otology (ISI). 2013; 9(3): 343-348.

A11. Vuralkan E, Mutlu M, Firat İ. H, Akaydin S, Sagit M, Akin İ, Miser E, Ardic S. Changes in serum levels of MDA and MMP-9 after UPF in patients with OSAS. European Archives of Oto-Rhino-Laryngology (ISI). 2013 Nov 19. DOI: 10.1007/s00405-13-2821-5

A12. Vuralkan E, Cobanoglu HB, Arslan A, Arslan S, Mungan S, Tatar S, Toklu AS. Effects of topical nasal steroids and diclofenac on the nasal mucosa during hyperbaric oxygen therapy: A double-blind experimental study. European Archives of Oto-Rhino-Laryngology (ISI). DOI: 10.1007/s00405-013-2863-8

A13. Vuralkan E, Sonbay D, Conkbayır I, Saka C, Alicura Tokgöz S, Akın I, Günsoy B. Flow Evaluation of the Internal Jugular Vein after Neck Dissection. Journal of Otology & Rhinology 2014, 3:3 (doi.org/10.4172/2324-8785.1000155)

A14. Mutlu M, Vuralkan E, Akaydin S, Akin İ, Miser E. Effects of adenoid/tonsillectomy on inflammatory response in snoring children with witnessed apnea. Clinical Otolaryngology (ISI), 2014

A15. Mutlu M, Vuralkan E, Akaydin S, Akin İ, Miser E. Alteration of serum levels of inflammatory cytokines and polysomnographic indices after uvulopalatal flap surgery in obstructive sleep apnea. Ear Nose & Throat Journal (ISI), 2017 Feb;96(2):65-68..

A16. Arslan S, Vuralkan E, Çobanoğlu B, Arslan A, Ural A. Giant sialolith of submandibular gland: report of a case. J Surg Case Rep. 2015 Apr 5;2015(4).

A17. Çobanoğlu B, Vuralkan E, Yeğengil Ç, Hemşinli D, Saylan S. What do Head and Neck Surgery and Orthopedics have in Common? An Unusual Case of Metallic Foreign Body. J Trauma Treat 2014, 4:1

A18. Alicura Tokgöz S, Şimşek G, Vuralkan E, Bayır Ö, Köybaşıoğlu F, Çalışkan M, Beşaltı O, Akın I. Effects of methotrexate in a toluene diisocyanate-induced allergic rhinitis rat model. Tr-ENT 2018;28(1):34-39

A19. Vuralkan E, Cobanoglu HB, Mirasoglu B, Mungan S, Arslan A, Bagli BS, Toklu AS, Türkmen IU. May Hyperbaric Oxygen Therapy Play a Role in the Treatment of Allergic Rhinitis? A Double- Blind Experimental Study in Rat Model Hyperbaric Oxygen Therapy on Allergic Rhinitis. J Otol Rhinol 2018, 7:1.

A20. Alicura Tokgoz S, Simsek G, Vuralkan E, Caliskan M , Besalti O, Akin I. Does melatonin alleviate ototoxic effect caused by administration of cisplatin? Annals of Medical Research 2019;26(11):2604-8

A21. Yaldız Çobanoğlu HB, Vuralkan E, Arslan A, Mirasoglu B, Toklu AS. Is Hyperbaric Oxygen Therapy Effective in Cisplatin-Induced Ototoxicity in Rats? CEO, 2019;(12) 66-71.

A22. Sonbay Yilmaz ND, Saka C, Alicura Tokgöz S, Çalişkan M, Vuralkan E, Beşalti Ö. Effects of acute hypoxia on auditory pathway of Wistar albino rats. Turkish Journal of Medical Sciences,2020; 50(6):1580-1584

B.International scientific conferences, and published in the proceedings:

B1. Clinical approach and results for supraglottic carcinoma patients: A retrospective analysis, 3. Türk-İtalyan Larengoloji Kongresi, Chieti/Pescara-Italia, 14-17.October.2004

B2. The Effectiveness of the Epley Maneuver and Brandt/Daroff Exercises for the Treatment of Benign Paroxysmal Positional Vertigo, World Congress of Physical Medicine and Rehabilitation

C.Articles published in national journals:

C1. Saka C, Kuran G, Sağıt M, Akın İ, Vuralkan E, Serin E. Radiofrequency ablation of the soft palate in the treatment of snoring and mild obstructive sleep apnea syndrome. KBB-Forum 2007;6 (4): 132-7.

C2. Akın İ, Vuralkan E, Sağıt M, Ceylan BT, Kuran G. Partial surgical treatment of early stage glottic carcinomas. Turk Arch Otolaryngol 2008; 46 (1): 16-21

C3. Vuralkan E, Akın İ, Kuran G, Saka C, Akçayöz N, Alicura S. Prognostic factors in laryngeal cancer. Kulak Burun Bogaz Ihtis Derg 2008;18(4): 221-226

C4. Aydın E, Ceylan BT, Vuralkan E, Hücümenoğlu S, Oktay M, Akın İ. A rare cause of benign cervical lymphadenopathy: Kikuchi-Fujimato Disease. J Med Sci 2008;28(6):999-1001

C5. Saka C, Kuran G, Vuralkan E, Gökler A, Akın İ. The effectiveness of endoscopic sinus surgery in nasal polyposis. Kulak Burun Bogaz Ihtis Derg 2008;18(5):306-311

C6. Ceylan BT, Akın İ, Ünlü E, Sağıt M, Vuralkan E. Effect of Botulinum toxin management of spasmodic dysphonia on life quality of patients. KBB-Forum 2008;7(3): 75-81

C7. Akın I, Sağıt M, Kuran G, Salman N, Vuralkan E, Mutlu M, Şahan M. Surgical treatment modalities in lower lip cancers. Turk Arch Otolaryngol 2009; 47(2): 83-89

C8. Yılmaz O, Kuran G, Vuralkan E, Sağıt M, Elverici O. Hearing loss in elderly people. Turk J Geriatrics 2010; 13 (1): 5-7

C9. Simsek G, Vuralkan E, Alicura Tokgöz S, Hudaynazarov U, Akın İ, Köybaşıoğlu F. A Case of Atypically-Localized Oncocytoma. J İnönü University Medical Faculty 2012;19(3):181-3.

C10. Akın I, Vuralkan E, Gunsoy B, Saka C, Akcayoz N, Simsek G. Supraglottik larenks kanserlerinin cerrahi tedavisinde onkolojik sonuçlarımız. Journal of Medical Updates 2013;3(1):8-12

C11. Şimşek G, Saka C, Vuralkan E, Serin E, Akın İ. Başağrısının Nadir Bir Nedeni: Süperior Konka Aşırı Pnömatizasyonu. Kocaeli MJ. 2015; 4(2): 41-43

C12. Hemsinli D, Ata Korkmaz HA, Baki G, Vuralkan E, Kaplan ST, Kul S, Turkmen IU. The role of vascular elastography and carotid artery intima media thickness methods in the determination of non-syndromic ascending thoracic aortic aneurysm. J Turgut Ozal Med Cent. 2018;25(1):1-6.

D.Presented at national conferences and published in the proceedings:

D1. “The relationship between perivascular invasion and lymphatic metastasis in larynx carcinoma” Multidisciplinary approach to head and neck cancers, Izmir, 26-28.Eylül.2004

D2. “Prognostic factors in larynx cancers” 29th National ORL-HNS Congress, Antalya, 26-31.May.2007

D3. “Uvula localized malignant tumor: a case report” 29th National ORL-HNS Congress, Antalya, 26-31. May.2007

D4. “Kuttner tumor of the submandibular salivary gland” 29th National ORL-HNS Congress, Antalya, 26-31. May.2007

D6. “Bilateral lower concha bullosa: a case report” 29th National ORL-HNS Congress, Antalya, 26-31. May.2007

D7. “Hearing loss in elderly people” 8th International Conference on Cholesteatoma and Ear Surgery, Antalya, 15-19. Haziran.2008

D8. “Facial nevre paralysis in temporal and parotideal trauma: Case report” 32nd National ORL-HNS Congress, Antalya, 27-31. October.2010

D9. ” Granulomatous Cervical Lymphadenitis: Case report” 32nd National ORL-HNS Congress, Antalya, 27-31. October.2010

D10. ” The effects of L-carnitine local use after myringotomy on myringosclerosis development in rats” 32nd National ORL-HNS Congress, Antalya, 27-31. October.2010

D11. “Adult cervical lymphangioma: a case report” 32nd National ORL-HNS Congress, Antalya, 27-31. October.2010

D12. ” The effects of CPAP treatment on nasal mucosa in patients with obstructive sleep apnea” 32nd National ORL-HNS Congress, Antalya, 27-31. October.2010

D13. “Parotidectomy in parotid masses: long-term results” 32nd National ORL-HNS Congress, Antalya, 27-31. October.2010

D14. “A rare cause of acute parotitis parotid duct foreign body” 32nd National ORL-HNS Congress, Antalya, 27-31. October.2010

D15. “Coexistence of Sjögren's syndrome and parotid pleomorphic adenoma: a case report” 32nd National ORL-HNS Congress, Antalya, 27-31. October.2010

D16. “Oncological results of surgical treatment of supraglottic laryngeal carcinoma” 32nd National ORL-HNS Congress, Antalya, 27-31. October.2010

D17. “The results of multilevel surgery in OSAS” 32nd National ORL-HNS Congress, Antalya, 27-31. October.2010

D18. “Our management of traumatic facial paralysis” 32nd National ORL-HNS Congress, Antalya, 27-31. October.2010

D19. “Anatomical and functional results of surgery in chronic otitis media” 32nd National ORL-HNS Congress, Antalya, 27-31. October.2010

D20.” Evaluation of the functions of the internal jugular vein after neck dissection” 32nd National ORL-HNS Congress, Antalya, 27-31. October.2010

D21. “Sarcomatoid carcinoma of the larynx: a rare case report” 32nd National ORL-HNS Congress, Antalya, 27-31. October.2010

D22. “A Case of Atypically-Localized Oncocytoma.” 32nd National ORL-HNS Congress, Antalya, 27-31. October.2010

D23. “Protective effects of melatonin in the prevention of cisplatin-induced ototoxicity in rats.” 33rd National ORL-HNS Congress, Antalya, 26-30. October.2011

E.Book chapters and translations:

E1. Akın I, Vuralkan E. Cervical Esophagus and Hypopharynx Cancers. In: Koç C, ed. Ear, Nose, Throat Diseases and Head-Neck Surgery. 2nd ed. Ankara: Güneş Kitabevi,2013. pp:879-95.

E2. Yılmaz O, Vuralkan E, Alicura Tokgöz S. Salivary Gland Infections. In: Koç C, ed. Ear, Nose, Throat Diseases and Head-Neck Surgery. 2nd ed. Ankara: Güneş Kitabevi,2013. pp:733-53.

E3. Yılmaz O, Vuralkan E, Alicura Tokgöz S. Salivary Gland Tumors. In: Koç C, ed. Ear, Nose, Throat Diseases and Head-Neck Surgery. 2nd ed. Ankara: Güneş Kitabevi,2013. pp:787-803.

E4. Sharen J. Knudsen Byron J (2011). Bailey Head&Neck Surgery – Otolaryngology, Steps in Medical Ethics (Trans. Vuralkan E). Ankara: Güneş Kitabevi, 2011. pp: 2781-9.

E5. Bowden MT. Otolaryngology and Facial Plastic Surgery Board Review, Head and Neck Oncology (Trans. Vuralkan E). Ankara: Güneş Kitabevi, 2012. pp: 293-343

Dr. Carlos Manuel Pollán Guisasola is a consultant ENT surgeon at Centro Médico Teknon and Hospital Germans Trias i Pujol in Barcelona. He specializes in endoscopic skull base surgery, head and neck oncology, and robotic surgery using the Da Vinci system. He earned his medical degree from the University of Santiago de Compostela. He completed his residency in Otorhinolaryngology through the MIR program at Vall d’Hebron University Hospital.

Dr. Pollán received advanced clinical training at the University of Pittsburgh and the University Hospital of Pisa. He leads the robotic head and neck surgery program at his hospitals. He is a faculty member at the ENT Teaching Unit of Germans Trias i Pujol. Dr. Pollán has published many peer-reviewed articles and frequently lectures at national and international conferences.

Dr. Avraam Abergel is a specialist in Otolaryngology and Hearing Impairment. He is the Deputy Head of the Department of Otolaryngology and the Acting Director of the Department of Hearing Impairment at Sourasky Medical Center.

Forbes ranked Dr. Abergel among the best doctors in Israel in 2021. He is known for his skill in advanced endoscopic sinus surgery, transsphenoidal pituitary tumor removal, and lacrimal duct procedures. He has a strong record in treating snoring, sleep apnea, and both benign and malignant tumors of the head and neck. This includes thyroid, throat, salivary gland, and nasopharyngeal cancers.

2013

Istanbul Florence Nightingale Hospital

Ear Nose Throat

1998 - 2013

Istanbul Surgery Hospital

Ear Nose Throat

1996 - 1997

Şişli Etfal Hospital

ENT Assistant Chief

1992 - 1996

Indiana Methodist Hospital

Ear Nose Throat

1992 - 1996

Institut Gustave Roussy, France

Observer Physician

1992 - 1995

Clinic of Professeur Frederic Chabolle at Suresnes Hopital Foch

Assistant Physician

1989 - 1992

Şişli Etfal Hospital

ENT Chief Assistant

1985 - 1989

Şişli Etfal and Marmara University Hospital

ENT Specialization

Dr. Ari Derowe is a Pediatric Otolaryngologist with 32 years of clinical experience. He leads the Pediatric Otolaryngology Unit at Ichilov Sourasky Medical Center in Tel Aviv. Dr. Derowe earned his medical degree and completed his specialization in Otorhinolaryngology at Sackler University. He also trained at Kaplan and Meir Hospitals.

Dr. Derowe teaches at Stanford School of Medicine. He is known for his work in pediatric ENT surgery. He is a member of the Israel Medical Association, the Israeli and American Societies of Otolaryngology, and the American Bronchoesophageal Association. These memberships show his strong professional reputation both in Israel and internationally.

Doctor Ophir Hendzel is a board certified otolaryngology specialist from Israel with an American background, specializing in cochlear implantations and complicated otology and neurobiology surgeries. He has a medical degree in otolaryngology from the Hebrew University of Jerusalem, and has received specialty training in otic and lateral skull base surgery, temporal bone surgery, and lateral skull base surgery from Harvard Medical School, House Ear Institute, and Saint Louis University, respectively. His work experience includes Board certification in the Cochlear Implant Unit at Sourasky Medical Center and the Otolaryngology Department at Assuta Clinic. He is a member of The Israeli Society of Otolaryngology/ Head and Neck Surgery, The Israel Otological Society, and The International Otological Society.

Professor Kyzas completed his PhD thesis in H&N Cancer with Honours (Αριστα), producing several highly cited influential publications. He has published > 70 scientific papers in high impact journals and has > 6000 citations.

Following his studies, Professor Kyzas has undertaken postgraduate training in the UK and was successful in securing a very competitive training post in the UK Higher Specialty Training Programme for Oral and Maxillofacial Surgery. He was trained in some of the biggest University Teaching hospitals in the North West of the UK. He has been awarded the Certificate of Completion of Training (CCT) in Oral and Maxillofacial Surgery by the General Medical Council (GMC). Subsequently, he was successful in securing one of the very few and prestigious UK-wide Training Interface (TIG) Fellowships in Head and Neck Surgical Oncology. He has successfully completed his fellowship and was awarded the subspecialty of Head and Neck Surgery by the Joint Committee of Surgical training (JCST).

In 2014 he has been appointed as a permanent substantive Consultant in Oral and Maxillofacial/Head and Neck Surgery in Manchester. He has treated hundreds of patients with Head and Neck cancer, offering state of the art major ablative and reconstructive surgery. He specialises in microvascular free tissue transfer and he has introduced and developed the 3D printer – personalised planning (PSP) reconstructive surgery in his hospital. He led his unit to become a reference centre by having the highest number of successful 3D PSP cases in the UK. Besides head and neck cancer, Professor Kyzas offers treatment to patients with facial skin cancer, oral and maxillofacial trauma, dentoalveolar surgery, orthognathic surgery, salivary gland diseases, facial cosmetic surgery, surgery of the temporomandibular joint, and anything else within the broad spectrum of Oral and Maxillofacial Surgery. He has performed many thousands of surgical procedures and has vast experience in any oral and maxillofacial condition. He has a special interest in the use of laser for oral pathologies and he is the Principal Investigator for an international trial examining the effectiveness of Transoral Laser resection in Ηead and Νeck Cancer. He is a certified microvascular surgeon and has accreditation in advanced trauma life support (ATLS).

Just before the covid pandemic, Professor Kyzas was presented with a unique opportunity to lead on the development of a Head and Neck Cancer Service in Lancashire. Professor Kyzas and his team managed to establish the service within months, and throughout the challenging covid period. The ELHT H&N Unit now produces oncological outcomes that compare favourably with any major H&N unit worldwide. Professor Kyzas has been appointed as the Clinical Director for all cancer services in ELHT, covering population of > 1M people.

In 2021, Professor Kyzas has been awarded the highly prestigious Bronze National Clinical Excellence Award for his overall services in the NHS. He was the youngest consultant to achieve this award and the only Cypriot OMFS surgeon ever to be considered for one.

Professor Kyzas has a long history of involvement in medical research. In 2007 he has completed his PhD thesis which has resulted in several highly cited publications in some of the most prestigious medical journals. He has participated in international collaborations for the improvement of medical research (http://progress-partnership.org/publications) and some of his papers have had a significant impact in improving research methodology. He has given several invited international lectures, and he has presented in national and international conferences. He has been a panel member for the selection committees for trainees in every level in oral and Maxillofacial Surgery in the UK. He is a regular peer-reviewer for many medical journals. He is the Lead trainer for the TIG H&N fellowship for his hospital and the Research Lead for his Deanery. He participates actively in Clinical Research, and he is the Principal Investigator for many clinical trials. He is a faculty member for the «Head and Neck resection tactics and free flap» course run by the Royal College of Surgeons of Edinburgh. He offers themed training in Head and Neck Oncological Surgery to medical students. In 2018 he was awarded the «Surgical Educator Excellence Award» by Health Education North West (HEENW). In the same year, he was nominated as doctor of the year in Northern Care Alliance.

Professor Kyzas is the Chief Investigator of the MANTRA trial, a UK multicentre RCT with multimillion pounds NIHR funding, launched in July 2023. This is the biggest randomised controlled trial ever to be performed in the specialty of OMFS.

As a result of his outstanding clinical and research/academic achievements, Professor Kyzas has been appointed as a visiting Professor in OMFS H&N Surgery at Edge Hill University

In 2018 Professor Kyzas was elected as the Deputy Editor for the British Journal of Oral and Maxillofacial Surgery (BJOMS). In January 2024, Professor Kyzas started his role as Editor in Chief for the BJOMS. This is the first time that a Greek Cypriot has ever been chosen for this highly prestigious role. Professor Kyzas sits in the council of the British Association of Oral and Maxillofacial Surgeons (BAOMS).

Professor Kyzas is a fully accredited medical expert witness and has provided hundreds of medical expert negligence reports (πραγματογνώμονας). In June 2024, Professor Kyzas has completed his Degree in Law with Honours (Άριστα), becoming a member of a very prestigious club of medical professionals with an active interest and certified knowledge in medicolegal practice.

Professor Kyzas is a fully accredited Oral and Maxillofacial Surgeon on the specialist register of the General Medical Council (GMC) UK, the Cyprus Medical Association (Cyprus), and the Cyprus Dental Association (Cyprus). In addition, he is also fully recognised and registered as Oral Surgeon by the General Dental Council (GDC) UK. He is a fellow of the Royal College of Surgeons (FRCSEd), member of the Faculty of Surgical Trainers (MFSTEd), fellow of the British Association of Oral and Maxillofacial Surgeons (BAOMS), member of the Hellenic Society of Head and Neck Oncology (HeSHNO) and member of the European Association of Craniomaxillofacial Surgery (ECAMFS).

I. Publications in International Journals

A. Experimental Studies

Doner F, Delibas N, Dogru H, Sari I, Yorgancigil B. Malondialdehyde Levels and Superoxide Dismutase Activity in Experimental Maxillary Sinusitis. Auris Nasus Larynx. 1999; 26(3): 287-91.

Döner F, Delibaş N, Dogru H, Yarıktaş M, Demirci M. The Role of Free Oxygen Radicals in Experimental Otitis Media. J Basis Clin Physiol Pharmacol. 2002; 13: 33-40.

Tuz M, Eroglu E, Dogru H, Delibas N, Tunc B, Uygur K. The Effect of Replacement Fluids and Normovolemic Hemodilution on the Survival of Dorsal Skin Flaps in Rats. Clin Otolaryngol. 2004; 29(1): 80-83.

Yarıktas M, Doner F, Ozguner F, Gokalp O, Dogru H, Delibas N. Nitric Oxide Level in the Nasal and Sinus Mucosa After Exposure to Electromagnetic Field. Otolaryngology-Head and Neck Surgery. 2004.

Experience

2017

Private Nisa Hospital

2011 - 2017

Yenibosna Private Ilke Hospital

2007 - 2011

Gaziosmanpaşa Private Bilge Hospital

Education

 2005 Bakırköy Dr. Sadi Konuk Training and Research Hospital, Ear Nose Throat Diseases 

2005 Bakırköy Dr. Sadi Konuk Training and Research Hospital, Ear Nose Throat Diseases 

2000 ISTANBUL UNIVERSITY FACULTY OF MEDICINE, Medical Education 

2000 ISTANBUL UNIVERSITY FACULTY OF MEDICINE, Medical Education